Stock Events

Stock Events

Whitehawk Therapeutics 

€3.54
40
+€0.04+1.14% Tuesday 19:55

Statistics

Day High
3.58
Day Low
3.42
52W High
3.54
52W Low
1.28
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
-0.42
-0.38
-0.34
-0.3
Expected EPS
-0.30508692499999995
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 3350.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Array Technologies
ARRY
Mkt Cap1.2B
Array BioPharma, acquired by Pfizer, focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat cancer, directly competing with Aadi Bioscience.
AMGEN
AMGN
Mkt Cap178B
Amgen has a broad portfolio of treatments, including for cancer, and its focus on innovative therapies makes it a competitor in the oncology space where Aadi Bioscience operates.
Exelixis
EXEL
Mkt Cap11.1B
Exelixis is focused on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers, competing with Aadi Bioscience's niche.
Incyte
INCY
Mkt Cap19.36B
Incyte Corporation has a strong focus on oncology, including targeted cancer therapies, making it a direct competitor to Aadi Bioscience.
Novartis
NVS
Mkt Cap279.67B
Novartis is a large pharmaceutical company with a significant investment in developing treatments for various cancers, including targeted therapies that compete with Aadi Bioscience.
Pfizer
PFE
Mkt Cap149.77B
Pfizer has a diverse oncology portfolio, including targeted therapies and precision medicine, making it a competitor in the same field as Aadi Bioscience.

About

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
Show more...
CEO
Dr. David J. Lennon Ph.D.
Employees
40
Country
United States
ISIN
US00032Q1040

Listings

XNAS
US
WHWK
MU
DE
3350.MU
F
DE
3350.F
STU
DE
3350.STU

0 Comments

Share your thoughts

FAQ

What is Whitehawk Therapeutics stock price today?▼
The current price of 3350.STU is €3.54 EUR — it has increased by +1.14% in the past 24 hours. Watch Whitehawk Therapeutics stock price performance more closely on the chart.
What is Whitehawk Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Whitehawk Therapeutics stocks are traded under the ticker 3350.STU.
Is Whitehawk Therapeutics stock price growing?▼
3350.STU stock has risen by +4.12% compared to the previous week, the month change is a +18.79% rise, over the last year Whitehawk Therapeutics has showed a +162.22% increase.
When is the next Whitehawk Therapeutics earnings date?▼
Whitehawk Therapeutics is going to release the next earnings report on May 07, 2026.
What were Whitehawk Therapeutics earnings last quarter?▼
3350.STU earnings for the last quarter are -0.3 EUR per share, whereas the estimation was -0.42 EUR resulting in a +29.55% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Whitehawk Therapeutics have?▼
As of May 06, 2026, the company has 40 employees.
In which sector is Whitehawk Therapeutics located?▼
Whitehawk Therapeutics operates in the Health & Wellness sector.
When did Whitehawk Therapeutics complete a stock split?▼
Whitehawk Therapeutics has not had any recent stock splits.
Where is Whitehawk Therapeutics headquartered?▼
Whitehawk Therapeutics is headquartered in Morristown, United States.